Given that 3D spheroid models act as more representative models of the original patient tumour, this research suggests that PARP inhibition in combination with radiotherapy should be investigated further as an effective combinatorial treatment for HNSCC and particularly for HPV-negative disease. The gene discussed is PARP1; the disease is head and neck squamous cell carcinoma.